Recurrent left bockdalek hernia in adult, a rare cause of subocclusive syndrome.
Chirurgia Bucur. Que es cancer broncogenico metastasis of cervix uteri carcinoma, rare cause of lower gastric stenosis. A phase II study of the cancer vaccine TG alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.
Cancer Immunol Immunother Feb;60 2 Metastatic renal carcinoma: evaluation of neuroendocrine cancer lung small cell therapy with dynamic contrast-enhanced CT. Radiology Aug; 2 Epub Jun What is the real impact of bone pain on survival in patients with metastatic hormone-refractory prostate cancer treated with docetaxel? BJU Int Jun; 12 Epub Neuroendocrine cancer lung small cell 6. Prostate-specific antigen kinetics in localized and advanced prostate neuroendocrine cancer lung small cell.
BJU Int Mar; 5 Salvage therapy with bevacizumab-sunitinib combination after failure of sunitinib alone for metastatic renal cell carcinoma: a case series. Eur Urol Jul;56 1quiz Epub Jan Therapeutic strategy for treatment of metastatic non-small cell lung cancer. Ann Pharmacother Nov;42 11 Oct Epub Oct Multiple lung cancers prognosis: what about histology?
Ann Thorac Surg Sep;86 3 Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy.
Spitalul Sf. Constantin: Dr. Eugeniu Banu
Eur Urol Sep;56 3 ;, Epub Jun Ann Thorac Surg ;86 1 Strategies and outcomes in pulmonary and extrapulmonary metastases from renal cell cancer.
Eur J Cardiothorac Surg May;33 5 Epub Mar 4. Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot. Cancer Apr; 7 Epub Feb Chemotherapy for prostate cancer.
Presse Med May; 37 5 Pt 2 Epub Dec Completely resected non-small cell lung cancer: reconsidering prognostic value and significance of N2 metastases. Ann Thorac Surg Dec;84 6 Drugs Aging ;24 10 Prostate-specific antigen doubling time before onset of chemotherapy as survival predictor for hormone-refractory prostate cancer patients. Ann Oncol Nov;18 11 Epub Sep 9.
Serum PSA half-life as neuroendocrine cancer lung small cell predictor of survival of hormone-refractory prostate cancer patients: Modelization using a standardised set of response criteria.
Prostate Oct;67 14 Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient.
Targeted Oncology Jul;2 3 New targeted therapies in hormone-refractory prostate cancer. Prospective multicenter phase II study of Gemcitabine plus platinum salt for metastatic collecting duct carcinoma patients.
J Urol May; Oudard, J. Medioni, A. Chedid, E.
Treatment update on neuroendocrine cancers
Banu, D. Dionysopoulos, J.
Balcaceres, F. Toxicity of antiangiogenic bevacizumab, sunitinib, sorafenib : summary and clinical practice management. Prostate cancer: update. Bull Cancer Oct;92 10 A multicenter study to evaluate the use of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand.
J Clin Oncol Jul;23 19 Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer. J Clin Oncol May;23 15 Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme.
V-ar putea interesa
J Neurooncol May;63 1 First-line chemotherapy with topotecan and etoposide in advanced small cell lung cancer.
A phase II study. J Buon Jan-Mar;7 1 The effect of low-dose amiodarone in prevention of paroxysmal atrial fibrillation. Peer-Reviewed Journal Articles on behalf of cooperative groups 1.
Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues. Breast Cancer Res Treat. Epub Aug Drug management of prostate cancer: prevalence and consequences of renal insufficiency. Clin Genitourin Cancer.
DR. EUGENIU BANU, MEDIC PRIMAR ONCOLOGIE MEDICALA
Renal insufficiency and anticancer drugs in elderly cancer patients: a subgroup analysis of the IRMA study. Crit Rev Oncol Hematol. Epub Nov.